Internal Medicine, Rheumatology · Royal Oak, MI
NPI
1255420766
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
30701 Woodward Ave Ste 314s
Royal Oak, MI, 48073
Phone (248) 955-9229
Groups this clinician bills Medicare through
Medicare paid, 2024
$603K
49,788 services
Medicare patients, 2024
545
Average age 74
Drug cost, 2024
$3.4M
5,062 prescriptions
Company payments, 2025
$4,816
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph G Skender was code J1602 (injection, golimumab, 1 mg, for intravenous use), 19,300 times for 30 patients. In total Joseph G Skender billed 49,788 services in 30 codes, and Medicare paid $603K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,300 | 30 | $8.86 | $171K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,450 | 15 | $34.01 | $151K |
| 99214 Office E&M - Established | Office | 859 | 370 | $92.59 | $80K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 430 | 251 | $12.80 | $5,506 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 412 | 20 | $0.10 | $42.31 |
| 96413 Chemotherapy Administration | Office | 245 | 53 | $101.91 | $25K |
| 99213 Office E&M - Established | Office | 194 | 144 | $66.69 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 174 | 41 | $0.76 | $132 |
| 20610 Joint Injection | Office | 75 | 61 | $51.80 | $3,885 |
| 99232 Hospital E&M - Subsequent | Facility | 71 | 42 | $63.35 | $4,498 |
| 99204 Office E&M - New | Office | 63 | 63 | $118.43 | $7,461 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 60 | 15 | $4.36 | $262 |
| 99203 Office E&M - New | Office | 34 | 34 | $84.58 | $2,876 |
| 99222 Hospital E&M - Initial | Facility | 27 | 26 | $105.74 | $2,855 |
| 99214 Office E&M - Established | Facility | 23 | 12 | $71.59 | $1,647 |
By year: 2022 $401K for 28,842 services; 2023 $383K for 27,358 services; 2024 $603K for 49,788 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph G Skender prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 921 prescriptions and refills. In total Joseph G Skender wrote 5,062 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 921 | 2,417 | 284 | $66K |
| Methotrexate Methotrexate Sodium | 739 | 1,630 | 206 | $30K |
| Prednisone Generic | 600 | 1,254 | 177 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 254 | 254 | 34 | $3,652 |
| Tizanidine Hcl Generic | 203 | 442 | 64 | $2,178 |
| Humira(Cf) Pen Adalimumab | 168 | 173 | 22 | $1.2M |
| Duloxetine Hcl Generic | 166 | 337 | 44 | $3,119 |
| Allopurinol Generic | 159 | 449 | 43 | $2,761 |
| Gabapentin Generic | 142 | 321 | 47 | $3,214 |
| Tramadol Hcl Generic | 142 | 159 | 27 | $778 |
| Methylprednisolone Generic | 137 | 182 | 80 | $1,745 |
| Sulfasalazine Generic | 126 | 306 | 46 | $5,088 |
| Enbrel Sureclick Etanercept | 110 | 110 | 19 | $798K |
| Leucovorin Calcium Generic | 88 | 211 | 27 | $2,522 |
| Leflunomide Generic | 84 | 180 | 31 | $4,949 |
Brand drugs: - claims; generic drugs: 4,455 claims; opioid claims: 453.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph G Skender $4,816 ($4,816 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $1,082.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 62 | $1,082 |
| Janssen Biotech, Inc. JNJ | 18 | $1,057 |
| UCB, Inc. UCB.BR | 25 | $678 |
| Abbvie Inc. ABBV | 22 | $546 |
| E.R. Squibb & Sons, L.L.C. BMY | 31 | $332 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $284 |
| Genzyme Corporation SNY | 15 | $281 |
| ANI Pharmaceuticals, Inc. ANIP | 6 | $144 |
| Invivyd Inc IVVD | 4 | $97.65 |
| Pfizer Inc. PFE | 3 | $62.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.